P&L Executive Summary | Period: Mar 2024
Revenue
$11,142,065
YTD: $34,541,959
Previous$10,912,604
MoM Chg.+2%
vs Budget-2%
Margin
8.04%
YTD: 15.90%
Previous12.75%
MoM Chg.-37%
vs Budget-40%
EBITDA
$146,895
YTD: $3,299,391
Previous$1,045,101
MoM Chg.-86%
vs Budget-69%
Net Result
$231,853
YTD: $3,573,441
Previous$1,135,031
MoM Chg.-80%
vs Budget-60%
Heads-Up Panel (Alerts AI)
Metric | Value | Commentary |
---|---|---|
OPEX | $850,720 | 7.64% Of re - OPEX are under control |
Monthly Profitability | $0.02 | Break-even zone |
EBITDA Breakeven Revenue | $10,576,006.86 | Break-even reached |
Situation vs. Breakeven | 5% | Just above breakeven |
Net per Unit revenue | $0.02 | For each unit of revenue, the company this month has gained 0.02 of Profit. |
P&L Health Summary - Mar 2024
The month is profitable, the company generates profit
Costs efficiency is maintained
Revenue of the month is able to cover the costs and bring profit
Executive Summary - AI Generated
Revenue grew by 2.1% month-on-month, a welcome change from the prior contraction, but still ended 2% below budget. Growth was broad-based, with Client 3 contributing most positively. However, Clients 1 and 2 showed little to no growth, signaling weak momentum from top accounts.
At the same time, COGS rose by 7.6%, far outpacing revenue growth. This drove a severe 35.6% drop in gross margin, pushing the business further below profitability thresholds. Margin recovery remained elusive across most clients, as inflationary pressures and inefficient pricing weigh.
Despite strong cost control — with salaries, admin, IT, and commissions all maintained within or below budget — the company could not prevent a collapse in profitability. EBITDA fell by 86%, reflecting poor absorption of overheads and margin leakage.
Finance income and cost both declined during the month. Although the finance contribution stayed net positive, it couldn't offset the operational weaknesses. Net profit plummeted to 232K, a 79.6% MoM drop, marking one of the sharpest deteriorations in recent quarters.
Revenue Evolution
Expense Composition
Salaries
Commissions & Bonuses
Advertising & Promotion
Travel & Entertainment
Logistics/Distribution
Other Selling Expenses
Revenue to EBITDA and Net Result (in M)
Increase
Decrease
Total
EBITDA Bridge (in M)
Increase
Decrease
Total
Action Plan
• Client Focus: Review supplier pricing and renegotiate costs. Engage top clients (especially Client 3) to support further sales growth, and revisit pricing/margin strategies for all accounts. Tighten cost controls and act swiftly to restore profitability. Deep-dive into client profitability and engagement strategies.
• Cost Discipline: Reassess OPEX allocations across fixed and variable lines. Optimize commission structures where revenue is volatile.
• Margin Improvement: Deploy margin bridge tools to isolate and respond to mix/pricing/cost deviations.
• Cash Flow & Resilience: Model downside scenarios for 2–3 months of continued pressure. Strengthen short-term financing buffers.
• Execution: Appoint a taskforce to align commercial recovery with pricing, procurement, and marketing strategies. Link team incentives to net margin KPIs.